RichFakirNSE · BSEOpen live analysis →

Gaudium IVF and Women Health Ltd

GAUDIUMIVF · Healthcare
Our view
Avoid
Quality score
65
Discount to fair value
-528%
See the full interactive analysis — quality radar, 12-year financials & more →
Fair value / share
₹19
Discount to fair value
-528%
Quality score
65/100
Return on equity
50.9%
Revenue growth (5y)
32.6%
P/E
36.5

Questions & answers

Is Gaudium IVF and Women Health Ltd (GAUDIUMIVF) a good business?

RichFakir rates Gaudium IVF and Women Health Ltd's business quality as decent — 65/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation).

Is Gaudium IVF and Women Health Ltd overvalued or undervalued?

On our model, Gaudium IVF and Women Health Ltd is trading far above our estimate of fair value (expensive on our lens); we rate its price expensive. This is an educational estimate from public filings, not a recommendation.

What is RichFakir's verdict on Gaudium IVF and Women Health Ltd (GAUDIUMIVF)?

RichFakir's educational verdict on Gaudium IVF and Women Health Ltd is: Avoid. We are steering clear of this one — the red flags below outweigh anything the price or numbers offer.

What is Gaudium IVF and Women Health Ltd's fair value?

RichFakir's educational estimate of Gaudium IVF and Women Health Ltd's fair value is about ₹19 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.

View the full live analysis →

Other companies

NEULANDLABSBILIFESOUTHBANKCLSELTAJGVKOBEROIRLTYHTELJSWDULUXTATACONSUMTATATECHVEEDOLTASTYBITE
RichFakir is an educational research tool, not investment advice. Figures are estimates from public filings and may contain errors. Do your own research.